Steven Cohen Ptc Therapeutics, Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
Call Options
3 transactions
Others Institutions Holding PTCT
# of Institutions
258Shares Held
77.4MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$475 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$403 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$383 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$330 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$248 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.71B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...